Abstract
Purpose
Both beta thalassemia and restless legs syndrome (RLS) patients share some common pathophysiological characteristics related to iron handling. In the present study, the aim was to explore the prevalence of RLS as well as to explore potential association between the syndrome and various quality of life-related parameters in a sample of beta thalassemia patients.
Methods
One hundred fourteen (age 40 ± 11 yr, 59 M/55F) beta thalassemia patients participated in this cross-sectional descriptive study. Patients were screened for RLS based on the international RLS study group diagnostic criteria as well as a battery of validated questionnaires.
Results
The prevalence of RLS in this sample of beta thalassemia patients was zero. The quality of life score was low (78 ± 18). Iron levels were within normal range (191 ± 66 mcg/dL) while ferritin levels were high as expected (1836 ± 225 ng/dL).
Conclusions
Our sample of patients comes from central Greece where the prevalence of RLS in the general population is 4% while in renal failure patients is 27%. To our surprise, there was no presence of RLS among this sample of beta thalassemia patients. The adequate levels of iron and ferritin often seen in these patients could be the reason of the absence of RLS symptoms.
This is a preview of subscription content, access via your institution.
References
Danjou F, Anni F, Galanello R (2011) Beta-thalassemia: from genotype to phenotype. Haematologica 96(11):1573–1575. doi:10.3324/haematol.2011.055962
Galanello R, Origa R (2010) Beta-thalassemia. Orphanet J Rare Dis 5:11. doi:10.1186/1750-1172-5-11
Montplaisir J, Godbout R, Poirier G, Bedard MA (1986) Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol 9(5):456–463
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4(2):101–119
Esposito M, Parisi P, Miano S, Carotenuto M (2013) Migraine and periodic limb movement disorders in sleep in children: a preliminary case-control study. J Headache Pain 14:57. doi:10.1186/1129-2377-14-57
Schormair B, Plag J, Kaffe M, Gross N, Czamara D, Samtleben W, Lichtner P, Strohle A, Stefanidis I, Vainas A, Dardiotis E, Sakkas GK, Gieger C, Muller-Myhsok B, Meitinger T, Heemann U, Hadjigeorgiou GM, Oexle K, Winkelmann J (2011) MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet 48(7):462–466. doi:10.1136/jmg.2010.087858
Inoue Y (2009) Diagnosis and symptom rating scale of restless legs syndrome. Brain and nerve = Shinkei kenkyu no shinpo 61(5):533–538
Oexle K, Schormair B, Ried JS, Czamara D, Heim K, Frauscher B, Hogl B, Trenkwalder C, Martin Fiedler G, Thiery J, Lichtner P, Prokisch H, Specht M, Muller-Myhsok B, Doring A, Gieger C, Peters A, Wichmann HE, Meitinger T, Winkelmann J (2013) Dilution of candidates: the case of iron-related genes in restless legs syndrome. Eur J Hum Genet 21(4):410–414. doi:10.1038/ejhg.2012.193
Mehmood T, Auerbach M, Earley CJ, Allen RP (2014) Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease). Sleep Med 15(12):1473–1476. doi:10.1016/j.sleep.2014.08.012
Allen RP, Auerbach S, Bahrain H, Auerbach M, Earley CJ (2013) The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol 88(4):261–264. doi:10.1002/ajh.23397
Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165(11):1286–1292. doi:10.1001/archinte.165.11.1286
Li X, Allen RP, Earley CJ, Liu H, Cruz TE, Edden RA, Barker PB, van Zijl PC (2016) Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla. Sleep Med 22:75–82. doi:10.1016/j.sleep.2016.05.001
Unger EL, Bianco LE, Jones BC, Allen RP, Earley CJ (2014) Low brain iron effects and reversibility on striatal dopamine dynamics. Exp Neurol 261:462–468. doi:10.1016/j.expneurol.2014.06.023
Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP (2005) Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry 76(7):1009–1010. doi:10.1136/jnnp.2003.030536
Akhlaghpoor S, Ghahari A, Morteza A, Khalilzadeh O, Shakourirad A, Alinaghizadeh MR (2012) Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of beta-thalassemia patients. Clin Neuroradiol 22(3):211–217. doi:10.1007/s00062-011-0108-z
Hadjigeorgiou GM, Stefanidis I, Dardiotis E, Aggellakis K, Sakkas GK, Xiromerisiou G, Konitsiotis S, Paterakis K, Poultsidi A, Tsimourtou V, Ralli S, Gourgoulianis K, Zintzaras E (2007) Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol 14(11):1275–1280. doi:10.1111/j.1468-1331.2007.01966.x
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4(2):121–132
Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Kyriakides T, Koutedakis Y, Stefanidis I (2013) Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol 14(1):194. doi:10.1186/1471-2369-14-194
Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Liakopoulos V, Tsianas N, Koukoulis GN, Koutedakis Y, Stefanidis I (2011) Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome. PLoS One 6(10):e25180. doi:10.1371/journal.pone
Bonner A, Wellard S, Caltabiano M (2008) Levels of fatigue in people with ESRD living in far North Queensland. J Clin Nurs 17(1):90–98. doi:10.1111/j.1365-2702.2007.02042.x
Zung WW, Richards CB, Short MJ (1965) Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 13(6):508–515
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12(12):2797–2806
Stefanidis I, Vainas A, Dardiotis E, Giannaki CD, Gourli P, Papadopoulou D, Vakianis P, Patsidis E, Eleftheriadis T, Liakopoulos V, Pournaras S, Sakkas GK, Zintzaras E, Hadjigeorgiou GM (2013) Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med 14(12):1381–1386. doi:10.1016/j.sleep.2013.05.022
Allen RP (2007) Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome. Am J Med 120(1 Suppl 1):S13–S21
Winkelman JW (2006) Considering the causes of RLS. Eur J Neurol 13(Suppl 3):8–14
Sakkas GK, Giannaki CD, Karatzaferi C, Maridaki M, Koutedakis Y, Hadjigeorgiou GM, Stefanidis I (2015) Current trends in the management of uremic restless legs syndrome: a systematic review on aspects related to quality of life, cardiovascular mortality and survival. Sleep Med Rev 21:39–49. doi:10.1016/j.smrv.2014.07.006
Srichairatanakool S, Thephinlap C, Phisalaphong C, Porter JB, Fucharoen S (2007) Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Med Chem 3(5):469–474
Zheng W, Monnot AD (2012) Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol Ther 133(2):177–188. doi:10.1016/j.pharmthera.2011.10.006
Papadimas J, Mandala E, Pados G, Kokkas B, Georgiadis G, Tarlatzis B, Bontis J, Sinakos Z, Mantalenakis S (1996) Pituitary-testicular axis in men with beta-thalassaemia major. Hum Reprod 11(9):1900–1904
Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23(1):1–25. doi:10.1016/j.mri.2004.10.001
Brass SD, Chen NK, Mulkern RV, Bakshi R (2006) Magnetic resonance imaging of iron deposition in neurological disorders. Topics in magnetic resonance imaging : TMRI 17(1):31–40. doi:10.1097/01.rmr.0000245459.82782.e4
Acknowledgements
We would like to thank all the patients who participated in the current study as well as the medical and nursing staff of the hematology unit of the General Hospital of Trikala, Larissa, and Karditsa.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this research.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Dimitriadou, E., Giannaki, C.D., Tsekoura, M. et al. Restless legs syndrome/Willis–Ekbom disease prevalence in beta thalassemia patients. Sleep Breath 22, 175–179 (2018). https://doi.org/10.1007/s11325-017-1497-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-017-1497-2
Keywords
- Anemia
- Iron
- Ferritin
- Sleep disorders